Antiretroviral and immunosuppressive drug-drug interactions: an update.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Kidney International

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1523-1755.2004.00772.XPMID 15253704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel renal amino acid transporters.

  2005cited by this paper
• Induction of cystine-glutamate transporter xc- by human immunodeficiency virus type 1 transactivator protein tat in retinal pigment epithelium.

  2004cited by this paper
• Differentiation of substrate and non-substrate inhibitors of transport system xc(-): an obligate exchanger of L-glutamate and L-cystine.

  2004cited by this paper
• Mercuric conjugates of cysteine are transported by the amino acid transporter system b(0,+): implications of molecular mimicry.

  2004cited by this paper
• Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation.

  2004cited by this paper
• Successful cardiac transplantation in an HIV-1-infected patient with advanced disease.

  2003cited by this paper
• Expression and regulation of L‐cystine transporter, system xc−, in the newly developed rat retinal Müller cell line (TR‐MUL)

  2003cited by this paper
• Kidney‐Pancreas Transplantation in a Long‐Term Non‐Progressor HIV‐Infected Recipient

  2003cited by this paper
• Orthotopic liver transplantation in patients with human immunodeficiency virus and end‐stage liver disease

  2003cited by this paper
• Follow-up of Antiretroviral Treatment in Liver Transplant Recipients with Primary and Chronic HIV Type 1 Infection

  2003cited by this paper
• Kidney-pancreas transplantation in a long-term non-progressor HIV-infected recipient.

  2003cited by this paper
• Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells.

  2003cited by this paper
• Regulation of L-cystine transport and intracellular GSH level by a nitric oxide donor in primary cultured rabbit conjunctival epithelial cell layers.

  2003cited by this paper
• Review of solid-organ transplantation in HIV-infected patients

  2003cited by this paper
• Drug Interactions Between Antiretroviral Drugs and Comedicated Agents

  2003influential reference
• The HIV-associated renal diseases: current insight into pathogenesis and treatment.

  2003cited by this paper
• Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study1

  2003cited by this paper
• Expression of the activity of cystine/glutamate exchange transporter, system x(c)(-), by xCT and rBAT.

  2003cited by this paper
• Stable Polarized Expression of hCAT-1 in an Epithelial Cell Line

  2002cited by this paper
• Probable interaction between efavirenz and cyclosporine.

  2002cited by this paper
• Solid-organ transplantation in HIV-infected patients.

  2002cited by this paper
• Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System

  2002cited by this paper
• Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir.

  2002cited by this paper
• Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: A case report

  2002cited by this paper
• The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA.

  2002cited by this paper
• Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy.

  2002cited by this paper
• The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients

  2002cited by this paper
• Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells.

  2001cited by this paper
• Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc–

  2001cited by this paper
• Interactions médicamenteuses avec les antirétroviraux.

  2001cited by this paper
• Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors

  2001cited by this paper
• Current Issues in Therapeutic Drug Monitoring of Mycophenolic Acid: Report of a Roundtable Discussion

  2001cited by this paper
• Solid organ transplantation in HIV-infected individuals: obstacles and opportunities.

  2001cited by this paper
• Transplantation in the HIV+ Patient

  2001influential reference
• Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease

  2001cited by this paper
• [Drug interactions with antiretroviral agents].

  2001cited by this paper
• Molecular pharmacology of immunosuppressive agents in relation to their clinical use

  2000cited by this paper
• Molecular Cloning and Expression of Human xCT, the Light Chain of Amino Acid Transport System xc¯

  2000cited by this paper
• Organ transplantation in the HIV-infected patient

  2000cited by this paper
• NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.

  2000cited by this paper
• Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors

  2000cited by this paper
• Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV).

  2000cited by this paper
• Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

  2000cited by this paper
• Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome.

  1999cited by this paper
• Cyclosporine induces cancer progression by a cell-autonomous mechanism

  1999cited by this paper
• Syngeneic stem cell transplantation for HIV‐related lymphoma

  1999cited by this paper
• Cloning and Expression of a b0,+-like Amino Acid Transporter Functioning as a Heterodimer with 4F2hc Instead of rBAT

  1999cited by this paper
• Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients.

  1999cited by this paper
• Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins*

  1999cited by this paper
• Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.

  1999cited by this paper
• Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels.

  1999cited by this paper
• Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity.

  1999cited by this paper
• Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation.

  1998cited by this paper
• Induction of cystine transport via system x-c and maintenance of intracellular glutathione levels in pancreatic acinar and islet cell lines.

  1998cited by this paper
• Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A.

  1998cited by this paper
• Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein.

  1998cited by this paper
• Gag protein from human immunodeficiency virus type 1 assembles in the absence of cyclophilin A.

  1998cited by this paper
• Pharmacokinetics of tacrolimus (FK506) in primary orthotopic heart transplant patients.

  1998cited by this paper
• HIV-protease inhibitors.

  1998cited by this paper
• Azathioprine: clinical pharmacology and current indications in autoimmune disorders.

  1998cited by this paper
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

  1998cited by this paper
• HIV-1 protease inhibitors and the MDR1 multidrug transporter.

  1998cited by this paper
• HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

  1998cited by this paper
• Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient.

  1998cited by this paper
• Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.

  1998cited by this paper
• Human Immunodeficiency Virus Protease Inhibitors Serve as Substrates for Multidrug Transporter Proteins MDR1 and MRP1 but Retain Antiviral Efficacy in Cell Lines Expressing These Transporters

  1998cited by this paper
• Pharmacokinetic Interaction between Saquinavir and Cyclosporine

  1998cited by this paper
• Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients.

  1998cited by this paper
• Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV‐infected patients

  1997cited by this paper
• Interactions between tacrolimus and antimicrobial agents.

  1997cited by this paper
• Arsenic compound-induced increases in glutathione levels in cultured Chinese hamster V79 cells and mechanisms associated with changes in γ-glutamylcysteine synthetase activity, cystine uptake and utilization of cysteine

  1997cited by this paper
• The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells.

  1997cited by this paper
• Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89

  1997cited by this paper
• p-Glycoprotein-mediated transport of a fluorescent rapamycin derivative in renal proximal tubule.

  1997cited by this paper
• Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV‐infected patients

  1997cited by this paper
• Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction.

  1996cited by this paper
• Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.

  1996cited by this paper
• HIV protease inhibitors

  1996cited by this paper
• Pharmacokinetic Individualisation of Zidovudine Therapy

  1996cited by this paper
• Long-term follow-up of HIV positive asymptomatic patients having received cyclosporin A.

  1995cited by this paper
• Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.

  1995cited by this paper
• Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions

  1995cited by this paper
• Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year.

  1995cited by this paper
• THE EFFECT OF CYCLOSPORINE ON THE PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION TRANSMITTED BY TRANSPLANTATION–DATA ON FOUR CASES AND REVIEW OF THE LITERATURE

  1993cited by this paper
• Characterization of human type I and type II IMP dehydrogenases.

  1993cited by this paper
• Mechanisms of Action of Mycophenolic Acid

  1993cited by this paper
• Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.

  1992cited by this paper
• Modulation of multidrug-resistant multiple myeloma by cyclosporin

  1992cited by this paper
• Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON.

  1992cited by this paper
• Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat.

  1992cited by this paper
• Enhancement of glutathione levels in mouse peritoneal macrophages by sodium arsenite, cadmium chloride and glucose/glucose oxidase.

  1991cited by this paper
• Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review.

  1991cited by this paper
• In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443.

  1991cited by this paper
• Transplantation in HIV+ patients.

  1990cited by this paper
• Cyclosporine-induced deterioration in patients with AIDS.

  1989cited by this paper
• Characteristics of cystine uptake by cultured LLC-PK1 cells.

  1988cited by this paper
• United Network for Organ Sharing

  1988cited by this paper
• Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease.

  1988influential reference
• Induction of cystine transport activity in mouse peritoneal macrophages

  1987cited by this paper
• Transport of cystine and cysteine and cell growth in cultured human diploid fibroblasts: Effect of glutamate and homocysteate

  1982cited by this paper

• Tacrolimus toxicity management in a pregnant kidney transplant recipient with newly diagnosed human immunodeficiency virus: A case report

  2025cites this paper
• Pharmacokinetic Boosting of Calcineurin Inhibitors in Transplantation: Pros, Cons, and Perspectives

  2024cites this paper
• Assessing Long-Term Adverse Outcomes in Older Kidney Transplant Recipients: A Propensity Score-Matched Comparison of Early Steroid Withdrawal Versus Continuous Steroid Immunosuppression Using a Large Real-World Database

  2024cites this paper
• Evolution of heart transplant donor characteristics in the 21st century: A United States single center’s experience

  2024cites this paper
• Approach to the Patient: Diagnosis of Cushing Syndrome

  2022cites this paper
• Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection

  2022cites this paper
• Trasplante renal en pacientes con infección por el virus de la inmunodeficiencia humana:

  2022influential citation
• Corticosteroids Use and Incidence of Severe Infections in People Living with HIV Compared to a Matched Population

  2022cites this paper
• Retrospective Review of ART Regimens in HIV-Positive to HIV-Positive Kidney Transplant Recipients

  2022cites this paper
• Deceased Donor Kidney Transplantation in a Human Immunodeficiency Virus-Infected Recipient: A Case Report.

  2019cites this paper
• Antiviral activity of sirolimus in an HIV-positive kidney transplant recipient

  2019cites this paper
• Challenges of kidney transplantation in HIV positive recipients.

  2019cites this paper
• Pharmacokinetic Considerations with the Use of Antiepileptic Drugs in Patients with HIV and Organ Transplants

  2018cites this paper
• Review of Major Drug-Drug Interactions in Thoracic Transplantation

  2018cites this paper
• Autoimmune skin disease among dermatology outpatients in Botswana: a retrospective review

  2018cites this paper
• Treatment of ESKD in Acquired Immunodeficiency Syndrome

  2018cites this paper
• A challenging male patient with retroviral infection on highly active antiretroviral therapy issues with re-transplantation

  2017cites this paper
• First Liver Transplant in an HIV Patient in Colombia: Case Report and Literature Review

  2017cites this paper
• Heart transplantation bridged by mechanical circulatory support in a HIV‐positive patient

  2016cites this paper
• Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infections

  2015cites this paper
• Renal Transplantation in HIV-positive Renal Transplant Recipients: Experience at the Mannheim University Hospital.

  2015cites this paper
• A Case of Nephrotic Syndrome, Showing Evidence of Response to Saquinavir

  2015cites this paper
• A Simplified HAART Regimen with Raltegravir and Lamivudine, and Pharmacokinetic Interactions with a Combined Immunosuppressive Therapy with Tacrolimus and Everolimus in an HIV/HCV/HBV/HDV Patient after Liver Transplantation.

  2014cites this paper
• [I Guidelines of heart failure and heart transplantation in the fetus, in children and adults with congenital cardiopathy, The Brazilian Society of Cardiology].

  2014cites this paper
• Organ Transplantation and HIV Progress or Success? A Review of Current Status

  2013cites this paper
• Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus.

  2013cites this paper
• Solid Organ Transplants in HIV-Infected Patients

  2013cites this paper
• Perspectives on liver and kidney transplantation in the human immunodeficiency virus-infected patient.

  2013cites this paper
• Renal transplantation in HIV patients: A series of four cases

  2012cites this paper
• Renal transplantation in an HIV-2 positive recipient in Portugal

  2012cites this paper
• Fatal Lactic Acidosis in a Kidney Transplant Recipient on Combination Antiretroviral Therapy after Initiation of Tacrolimus Therapy

  2012cites this paper
• An update on immunosuppression for the HIV-positive kidney transplant recipient

  2012cites this paper
• [Clinical relevance of drug interactions].

  2011cites this paper
• Liver transplantation in HCV/HIV positive patients.

  2011cites this paper
• Safe use of Sunitinib in metastatic non-clear cell renal cell cancer in the setting of human immunodeficiency virus

  2011cites this paper
• [Organ transplants in HIV infected patients. Update and recommendations].

  2011cites this paper
• [Kidney transplantation in HIV infected patients].

  2011cites this paper
• Transplante renal em pacientes infectados pelo HIV

  2011cites this paper
• Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients

  2011influential citation
• Renal transplantation in an HIV-infected patient: Pharmacokinetic aspects

  2011cites this paper
• Pulmonary tuberculosis in an HIV- and hepatitis C virus-coinfected kidney-pancreas transplant recipient: a case report.

  2011cites this paper
• Safe use of Sunitinib in metastatic non-clear cell renal cell cancer in the setting of human immunodeficiency virus

  2011cites this paper
• Management of HIV-infected patients with ESRD.

  2010cites this paper
• Transplante renal em pacientes infectados pelo HIV

  2010cites this paper
• Kidney transplantation in patients with HIV infection.

  2010cites this paper
• Recipient-based approach to tailoring immunosuppression in liver transplantation.

  2010cites this paper
• State of the art in therapeutic drug monitoring

  2010cites this paper
• [Liver transplantation in patients with HIV infection].

  2010cites this paper
• Human immunodeficiency virus and renal transplantation.

  2009cites this paper
• Renal transplantation in a HIV positive patient

  2009influential citation
• Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review.

  2009cites this paper
• Effect of coadministered HIV‐protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipients

  2009cites this paper
• Medikamenteninteraktionen in der Geriatrie

  2009cites this paper
• Safety and Efficacy of Raltegravir in HIV‐Infected Transplant Patients Cotreated with Immunosuppressive Drugs

  2009cites this paper
• Successful Lung Transplantation in an HIV‐ and HBV‐Positive Patient with Cystic Fibrosis

  2009cites this paper
• Kidney transplantation in HIV-positive patients: report of our first 7 cases.

  2009cites this paper
• Liver transplantation in HIV‐positive patients

  2009cites this paper
• Enfuvirtide: A safe and effective antiretroviral agent for human immunodeficiency virus–infected patients shortly after liver transplantation

  2009cites this paper
• Renal transplantation in developing countries

  2008cites this paper
• HIV and the kidney.

  2008cites this paper
• Impact of Human Immunodeficiency Virus on Survival After Liver Transplantation: Analysis of United Network for Organ Sharing Database

  2008cites this paper
• Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study

  2007cites this paper
• Kaletra® Single Agent HAART after Intolerance of NRTI- and NNRTI-Containing Regimens Following Kidney Transplantation

  2007cites this paper
• Liver transplantation in HIV-HCV coinfected patients: a case-control study.

  2007cites this paper
• Selective Inhibition of Porcine Endogenous Retrovirus Replication in Human Cells by Acyclic Nucleoside Phosphonates

  2007cites this paper
• The challenge of managing drug interactions in elderly people.

  2007cites this paper
• [Approach to evaluating the clinical relevance of drug interactions in HIV-infected patients].

  2007cites this paper
• Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women

  2007cites this paper
• Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report.

  2007cites this paper
• [Immunosuppressive drugs and highly active antiretroviral therapy: pharmacokinetic interactions].

  2007cites this paper
• Renal transplant in an HIV-positive patient.

  2007cites this paper
• Aspects of immune activation in HIV-1 infection

  2007cites this paper
• Interacciones medicamentosas en pacientes infectados con el VIH: aproximación para establecer y evaluar su relevancia clínica

  2007cites this paper
• Médicaments immunosuppresseurs et antirétroviraux : une association riche en interactions

  2007cites this paper
• Life‐threatening interaction between antiretroviral therapy and vinblastine in HIV‐associated multicentric Castleman's disease

  2006cites this paper
• Guidelines for kidney transplantation in patients with HIV disease *

  2006cites this paper
• Handling sirolimus in clinical practice

  2006cites this paper
• Liver Transplantation in HIV-Infected Patients: Update in 2006

  2006cites this paper
• HIV-Positive Renal Recipients Can Achieve Survival Rates Similar to Those of HIV-Negative Patients

  2006cites this paper
• HIV and end-stage renal disease: Practical issues in management

  2006cites this paper
• [Renal transplantation in HIV-infected patients in Spain].

  2006cites this paper
• Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)?

  2006cites this paper
• Handling sirolimus in clinical practice. Spanish Nephrology Society.

  2006cites this paper
• Management of the Well Renal Transplant Recipient: Outpatient Surveillance and Treatment Recommendations

  2005cites this paper
• Drug-Drug Interactions and HIV Therapy: What Should Pharmacists Know?

  2005cites this paper
• Documento de consenso GESIDA/GESITRA-SEIMC, SPNS y ONT sobre trasplante de órgano sólido en pacientes infectados por el VIH en España (marzo 2005)

  2005cites this paper
• Determination of adefovir in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study.

  2005cites this paper
• [GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005)].

  2005cites this paper
• Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists.

  2005cites this paper
• Dialyzing a Patient with Human Immunodeficiency Virus Infection: What a Nephrologist Needs to Know

  2004cites this paper
• Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression.

  2004cites this paper
• Evidence-based medicine: the dilemma of transplantation in patients with HIV infection

  2004cites this paper
• Additional antiretroviral and immunosuppressive drug-drug interactions.

  2004cites this paper
• Follow-up of Antiretroviral Treatment in Liver Transplant Recipients with Primary and Chronic HIV Type 1 Infection

  2003cites this paper
• Open Access Rheumatology: Research and Reviews Dovepress Rheumatoid Arthritis in Patients with Hiv: Management Challenges

  year unknowncites this paper
• EUR Research

  year unknowncites this paper